(Q34345249)

English

Going from immutable to mutable atherosclerotic plaques

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

Going from immutable to mutable atherosclerotic plaques (English)

1 reference

Europe PubMed Central

1 August 2017

atherosclerosis

1 reference

based on heuristic

inferred from title

author name string

Davies MJ

1

1 reference

Europe PubMed Central

1 August 2017

language of work or name

0 references

publication date

1 August 2001

1 reference

Europe PubMed Central

1 August 2017

American Journal of Cardiology

1 reference

Europe PubMed Central

1 August 2017

88

1 reference

Europe PubMed Central

1 August 2017

2F-9F

1 reference

Europe PubMed Central

1 August 2017

4A

1 reference

Europe PubMed Central

1 August 2017

Morphological characteristics of clinically significant coronary artery stenosis in stable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Morphometric analysis of the composition of atherosclerotic plaques in the four major epicardial coronary arteries in acute myocardial infarction and in sudden coronary death

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Coronary risk factors and plaque morphology in men with coronary disease who died suddenly

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Molecular bases of the acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Morphology of the endothelium over atherosclerotic plaques in human coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Coronary plaque disruption.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Plaque erosion is a major substrate for coronary thrombosis in acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

The composition of coronary-artery plaques

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Coronary angiographic morphology in myocardial infarction: a link between the pathogenesis of unstable angina and myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Coronary thrombi increase PTCA risk. Angioscopy as a clinical tool

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Pathological concepts in acute coronary thrombosis: relevance to treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Angiographic stenosis progression and coronary events in patients with 'stabilized' unstable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Factors influencing the presence or absence of acute coronary artery thrombi in sudden ischaemic death

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Atherogenic Diets Enhance Endotoxin-Stimulated Interleukin-1 and Tumor Necrosis Factor Gene Expression in Rabbit Aortae

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Mechanisms of progression in native coronary artery disease: role of healed plaque disruption.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Antiatherothrombotic properties of statins: implications for cardiovascular event reduction.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Animal models of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Effects of low-dose pravastatin sodium on plasma cholesterol levels and aortic atherosclerosis of heterozygous WHHL rabbits fed a low cholesterol (0.03%) enriched diet for one year

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Plaque changes and arterial enlargement in atherosclerotic monkeys after manipulation of diet and social environment

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Reduction of serum cholesterol levels alters lesional composition of atherosclerotic plaques. Effect of pravastatin sodium on atherosclerosis in mature WHHL rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

The influence of pretreatment low density lipoprotein cholesterol concentrations on the effect of hypocholesterolemic therapy on coronary atherosclerosis in angiographic trials. Harvard Atherosclerosis Reversibility Project Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Low-density lipoprotein-independent effects of statins

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Increased bioavailability of nitric oxide after lipid-lowering therapy in hypercholesterolemic patients: a randomized, placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Simvastatin decreases aldehyde production derived from lipoprotein oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Direct vascular effects of HMG-CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Direct effects of statins on the vascular wall

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Lovastatin inhibits low-density lipoprotein oxidation and alters its fluidity and uptake by macrophages: in vitro and in vivo studies

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Lovastatin reduces expression of the combined adhesion and scavenger receptor CD36 in human monocytic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Vastatins Inhibit Tissue Factor in Cultured Human Macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Randomized placebo-controlled study of the effects of simvastatin on haemostatic variables, lipoproteins and free fatty acids. The Oxford Cholesterol Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Effect of lovastatin on intimal hyperplasia after balloon angioplasty: A study in an atherosclerotic hypercholesterolemic rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Progression of coronary artery disease predicts clinical coronary events. Long-term follow-up from the Cholesterol Lowering Atherosclerosis Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Plaque stabilization: a mechanism for the beneficial effect of lipid-lowering therapies in angiography studies

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Modification of coronary artery disease progression by cholesterol-lowering therapy: the angiographic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Rationale and design of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study that evaluates atorvastatin in unstable angina pectoris and in non-Q-wave acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Mutations in the low-density lipoprotein receptor gene in Swedish familial hypercholesterolaemia patients: clinical expression and treatment response

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Chronic infections and coronary heart disease: is there a link?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Kinetics of calcium and calmodulin-dependent protein kinase III from embryonic chicken leg muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901870-7

7 January 2021

Identifiers

10.1016/S0002-9149(01)01870-7

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34345249&oldid=2038957815"